Announce Date | 09/23/2025 |
EPS Normalized Actual | $3.03 (Beat by $0.17) |
EPS GAAP Actual | $3.03 (Beat by $0.17) |
Revenue Actual | $11.315B |
Revenue Surprise | Beat by $11315M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Aug 2028 | 14.18 | 13.25 | 12.43223 | 15.88951 | 5 |
Aug 2027 | 0 | INF | 0 | 0 | 7 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ3 2025 (Aug 2025) | 2.86 | 2.86 | 11.315B | 31.51% | 11315M |
FQ2 2025 (May 2025) | 1.69 | 1.69 | 9.301B | 26.77% | 9301M |
FQ1 2025 (Feb 2025) | -1.68 | -1.68 | 8.053B | 27.68% | 8053M |
FQ4 2024 (Nov 2024) | 1.68 | 1.68 | 8.709B | 45.73% | 8709M |
FQ3 2024 (Aug 2024) | 0.8 | 0.8 | 7.75B | 48.26% | 7750M |
FQ2 2024 (May 2024) | 0.3 | 0.3 | 6.811B | 44.91% | 6811M |
FQ1 2024 (Feb 2024) | 0.72 | 0.72 | 5.824B | 36.59% | 5824M |
FQ4 2023 (Nov 2023) | -1.12 | -1.12 | 4.726B | 13.56% | 4726M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2028 (Aug 2028) | 5.78455 | -- | 5.49406 | 6.13027 | 7 |
FQ2 2028 (May 2028) | 5.13783 | -- | 4.87982 | 5.4449 | 7 |
FQ1 2028 (Feb 2028) | 4.77187 | -- | 4.53224 | 5.05707 | 7 |
FQ4 2027 (Nov 2027) | 3.19 | -- | 2.67602 | 3.3916 | 18 |
FQ3 2027 (Aug 2027) | 3.2174 | -- | 3.17597 | 3.24628 | 11 |
FQ2 2027 (May 2027) | 3.21165 | -- | 3.1703 | 3.24048 | 11 |
FQ1 2027 (Feb 2027) | 3.45709 | -- | 2.90007 | 3.67557 | 12 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2028 (Aug 2028) | 18.03B | -- | 17.34B | 18.86B | 11 |
FQ2 2028 (May 2028) | 16.2B | -- | 15.57B | 16.94B | 7 |
FQ1 2028 (Feb 2028) | 15.3B | -- | 14.71B | 16B | 7 |
FQ4 2027 (Nov 2027) | 12.29B | -- | 10.77B | 12.89B | 11 |
FQ3 2027 (Aug 2027) | 11.91B | -- | 11.79B | 11.99B | 18 |
FQ2 2027 (May 2027) | 12.12B | -- | 12B | 12.2B | 12 |
FQ1 2027 (Feb 2027) | 12.63B | -- | 11.07B | 13.25B | 11 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2025 (Aug 2025) | 2.86 | 2.86 | 100% | |
FQ2 2025 (May 2025) | 1.69 | 1.69 | 100% | |
FQ1 2025 (Feb 2025) | -1.68 | -1.68 | 100% | |
FQ4 2024 (Nov 2024) | 1.68 | 1.68 | 100% | |
FQ3 2024 (Aug 2024) | 0.8 | 0.8 | 100% | |
FQ2 2024 (May 2024) | 0.3 | 0.3 | 100% | |
FQ1 2024 (Feb 2024) | 0.72 | 0.72 | 100% | |
FQ4 2023 (Nov 2023) | -1.12 | -1.12 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2025 (Aug 2025) | $0B | $11.32B | $11315M | 100% |
FQ2 2025 (May 2025) | $0B | $9.3B | $9301M | 100% |
FQ1 2025 (Feb 2025) | $0B | $8.05B | $8053M | 100% |
FQ4 2024 (Nov 2024) | $0B | $8.71B | $8709M | 100% |
FQ3 2024 (Aug 2024) | $0B | $7.75B | $7750M | 100% |
FQ2 2024 (May 2024) | $0B | $6.81B | $6811M | 100% |
FQ1 2024 (Feb 2024) | $0B | $5.82B | $5824M | 100% |
FQ4 2023 (Nov 2023) | $0B | $4.73B | $4726M | 100% |